Automated World Health
L29162 EXTERNAL ELECTROCARDIOGRAPHIC RECORDING
10/08/2012
Indications and Limitations of Coverage and/or Medical Necessity
This coverage policy is being developed to clearly define the circumstances for which twenty-four hour continuous electrocardiographic monitoring is considered to be medically reasonable and necessary, and therefore covered, by Medicare.
Medicare will consider twenty-four hour electrocardiographic monitoring to be medically necessary in any of the following circumstances (see Covered ICD-9 Codes):
• The patient complains of palpitations, and physical examination and standard EKG have not satisfactorily explained the patient's complaints.
• The patient has experienced an unexplained syncopal episode or the patient has experienced a transient episode of cerebral ischemia which is felt to possibly be secondary to a cardiac rhythm disturbance.
• The patient has been found to have a significant cardiac arrhythmia or conduction disorder (see list below) and holter monitoring is necessary as part of the evaluation and management of the patient:
o Complete Heart Block
o Second Degree AV Block
o New Left Bundle Branch Block
o New Right Bundle Branch Block
o Bifasicular Block
o Paroxysmal SVT
o Paroxysmal VT
o Atrial Fib/Flutter
o Ventricular Fib/Flutter
o Cardiac Arrest
o SA Node Dysfunction
o Frequent PAC's
o Frequent PVC's
o Wandering Atrial Pacemaker
o Unspecified Cardiac Arrhythmia
• The patient has a heart condition (see list below) associated with a high incidence of serious cardiac arrhythmia and/or myocardial ischemia, and holter monitoring is being done as part of the evaluation and management of the patient:
o Dressler's Syndrome
o History of Myocardial Infarction
o Angina Pectoris
o Prinzmetals's Angina
o Aneurysm of Heart Wall
o Chronic Ischemic Heart Disease
o Pericarditis
o Mitral Valve Disease
o Cardiomyopathy
o Anomalous AV Excitation
o Cardiomegaly
o Post Heart Surgery
o Prolonged QT Interval
• The patient has a cardiac arrhythmia or other cardiac condition and a cardiac medication which affects the electrical conduction system of the heart has been prescribed, and holter monitoring is necessary to evaluate the effect of the cardiac medication on the patient's cardiac rhythm and/or conduction system.
• The patient has a pacemaker and clinical findings (history or physical examination) suggest possible pacemaker malfunction.
• Claims submitted for holter studies performed at unusually frequent intervals will be reviewed by Medicare to make certain that the services were medically reasonable and necessary.
CPT/HCPCS Codes
93224 EXTERNAL ELECTROCARDIOGRAPHIC RECORDING UP TO 48 HOURS BY CONTINUOUS RHYTHM RECORDING AND STORAGE; INCLUDES RECORDING, SCANNING ANALYSIS WITH REPORT, PHYSICIAN REVIEW AND INTERPRETATION
93225 EXTERNAL ELECTROCARDIOGRAPHIC RECORDING UP TO 48 HOURS BY CONTINUOUS RHYTHM RECORDING AND STORAGE; RECORDING (INCLUDES CONNECTION, RECORDING, AND DISCONNECTION)
93226 EXTERNAL ELECTROCARDIOGRAPHIC RECORDING UP TO 48 HOURS BY CONTINUOUS RHYTHM RECORDING AND STORAGE; SCANNING ANALYSIS WITH REPORT
93227 EXTERNAL ELECTROCARDIOGRAPHIC RECORDING UP TO 48 HOURS BY CONTINUOUS RHYTHM RECORDING AND STORAGE; PHYSICIAN REVIEW AND INTERPRETATION
ICD-9 Codes that Support Medical Necessity
410.00 ACUTE MYOCARDIAL INFARCTION OF ANTEROLATERAL WALL EPISODE OF CARE UNSPECIFIED
410.01 ACUTE MYOCARDIAL INFARCTION OF ANTEROLATERAL WALL INITIAL EPISODE OF CARE
410.02 ACUTE MYOCARDIAL INFARCTION OF ANTEROLATERAL WALL SUBSEQUENT EPISODE OF CARE
410.10 ACUTE MYOCARDIAL INFARCTION OF OTHER ANTERIOR WALL EPISODE OF CARE UNSPECIFIED
410.11 ACUTE MYOCARDIAL INFARCTION OF OTHER ANTERIOR WALL INITIAL EPISODE OF CARE
410.12 ACUTE MYOCARDIAL INFARCTION OF OTHER ANTERIOR WALL SUBSEQUENT EPISODE OF CARE
410.20 ACUTE MYOCARDIAL INFARCTION OF INFEROLATERAL WALL EPISODE OF CARE UNSPECIFIED
410.21 ACUTE MYOCARDIAL INFARCTION OF INFEROLATERAL WALL INITIAL EPISODE OF CARE
410.22 ACUTE MYOCARDIAL INFARCTION OF INFEROLATERAL WALL SUBSEQUENT EPISODE OF CARE
410.30 ACUTE MYOCARDIAL INFARCTION OF INFEROPOSTERIOR WALL EPISODE OF CARE UNSPECIFIED
410.31 ACUTE MYOCARDIAL INFARCTION OF INFEROPOSTERIOR WALL INITIAL EPISODE OF CARE
410.32 ACUTE MYOCARDIAL INFARCTION OF INFEROPOSTERIOR WALL SUBSEQUENT EPISODE OF CARE
410.40 ACUTE MYOCARDIAL INFARCTION OF OTHER INFERIOR WALL EPISODE OF CARE UNSPECIFIED
410.41 ACUTE MYOCARDIAL INFARCTION OF OTHER INFERIOR WALL INITIAL EPISODE OF CARE
410.42 ACUTE MYOCARDIAL INFARCTION OF OTHER INFERIOR WALL SUBSEQUENT EPISODE OF CARE
410.50 ACUTE MYOCARDIAL INFARCTION OF OTHER LATERAL WALL EPISODE OF CARE UNSPECIFIED
410.51 ACUTE MYOCARDIAL INFARCTION OF OTHER LATERAL WALL INITIAL EPISODE OF CARE
410.52 ACUTE MYOCARDIAL INFARCTION OF OTHER LATERAL WALL SUBSEQUENT EPISODE OF CARE
410.60 TRUE POSTERIOR WALL INFARCTION EPISODE OF CARE UNSPECIFIED
410.61 TRUE POSTERIOR WALL INFARCTION INITIAL EPISODE OF CARE
410.62 TRUE POSTERIOR WALL INFARCTION SUBSEQUENT EPISODE OF CARE
410.70 SUBENDOCARDIAL INFARCTION EPISODE OF CARE UNSPECIFIED
410.71 SUBENDOCARDIAL INFARCTION INITIAL EPISODE OF CARE
410.72 SUBENDOCARDIAL INFARCTION SUBSEQUENT EPISODE OF CARE
410.80 ACUTE MYOCARDIAL INFARCTION OF OTHER SPECIFIED SITES EPISODE OF CARE UNSPECIFIED
410.81 ACUTE MYOCARDIAL INFARCTION OF OTHER SPECIFIED SITES INITIAL EPISODE OF CARE
410.82 ACUTE MYOCARDIAL INFARCTION OF OTHER SPECIFIED SITES SUBSEQUENT EPISODE OF CARE
410.90 ACUTE MYOCARDIAL INFARCTION OF UNSPECIFIED SITE EPISODE OF CARE UNSPECIFIED
410.91 ACUTE MYOCARDIAL INFARCTION OF UNSPECIFIED SITE INITIAL EPISODE OF CARE
410.92 ACUTE MYOCARDIAL INFARCTION OF UNSPECIFIED SITE SUBSEQUENT EPISODE OF CARE
411.0 POSTMYOCARDIAL INFARCTION SYNDROME
411.1 INTERMEDIATE CORONARY SYNDROME
411.81 ACUTE CORONARY OCCLUSION WITHOUT MYOCARDIAL INFARCTION
411.89 OTHER ACUTE AND SUBACUTE FORMS OF ISCHEMIC HEART DISEASE OTHER
412 OLD MYOCARDIAL INFARCTION
413.0 ANGINA DECUBITUS
413.1 PRINZMETAL ANGINA
413.9 OTHER AND UNSPECIFIED ANGINA PECTORIS
414.00 CORONARY ATHEROSCLEROSIS OF UNSPECIFIED TYPE OF VESSEL NATIVE OR GRAFT
414.01 CORONARY ATHEROSCLEROSIS OF NATIVE CORONARY ARTERY
414.02 CORONARY ATHEROSCLEROSIS OF AUTOLOGOUS VEIN BYPASS GRAFT
414.03 CORONARY ATHEROSCLEROSIS OF NONAUTOLOGOUS BIOLOGICAL BYPASS GRAFT
414.06 CORONARY ATHEROSCLEROSIS OF NATIVE CORONARY ARTERY OF TRANSPLANTED HEART
414.07 CORONARY ATHEROSCLEROSIS OF BYPASS GRAFT (ARTERY) (VEIN) OF TRANSPLANTED HEART
414.10 ANEURYSM OF HEART (WALL)
414.11 ANEURYSM OF CORONARY VESSELS
414.19 OTHER ANEURYSM OF HEART
414.4 CORONARY ATHEROSCLEROSIS DUE TO CALCIFIED CORONARY LESION
414.8 OTHER SPECIFIED FORMS OF CHRONIC ISCHEMIC HEART DISEASE
414.9 CHRONIC ISCHEMIC HEART DISEASE UNSPECIFIED
423.1 ADHESIVE PERICARDITIS
423.2 CONSTRICTIVE PERICARDITIS
424.0 MITRAL VALVE DISORDERS
425.0 ENDOMYOCARDIAL FIBROSIS
425.11 HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
425.18 OTHER HYPERTROPHIC CARDIOMYOPATHY
425.2 OBSCURE CARDIOMYOPATHY OF AFRICA
425.3 ENDOCARDIAL FIBROELASTOSIS
425.4 OTHER PRIMARY CARDIOMYOPATHIES
425.5 ALCOHOLIC CARDIOMYOPATHY
425.7 NUTRITIONAL AND METABOLIC CARDIOMYOPATHY
425.8 CARDIOMYOPATHY IN OTHER DISEASES CLASSIFIED ELSEWHERE
425.9 SECONDARY CARDIOMYOPATHY UNSPECIFIED
426.0 ATRIOVENTRICULAR BLOCK COMPLETE
426.12 MOBITZ (TYPE) II ATRIOVENTRICULAR BLOCK
426.13 OTHER SECOND DEGREE ATRIOVENTRICULAR BLOCK
426.2 LEFT BUNDLE BRANCH HEMIBLOCK
426.4 RIGHT BUNDLE BRANCH BLOCK
426.53 OTHER BILATERAL BUNDLE BRANCH BLOCK
426.7 ANOMALOUS ATRIOVENTRICULAR EXCITATION
426.82 LONG QT SYNDROME
426.9 CONDUCTION DISORDER UNSPECIFIED
427.0 PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA
427.1 PAROXYSMAL VENTRICULAR TACHYCARDIA
427.31 ATRIAL FIBRILLATION
427.32 ATRIAL FLUTTER
427.41 VENTRICULAR FIBRILLATION
427.42 VENTRICULAR FLUTTER
427.5 CARDIAC ARREST
427.61 SUPRAVENTRICULAR PREMATURE BEATS
427.69 OTHER PREMATURE BEATS
427.81 SINOATRIAL NODE DYSFUNCTION
427.89 OTHER SPECIFIED CARDIAC DYSRHYTHMIAS
427.9 CARDIAC DYSRHYTHMIA UNSPECIFIED
429.3 CARDIOMEGALY
429.4 FUNCTIONAL DISTURBANCES FOLLOWING CARDIAC SURGERY
429.9 HEART DISEASE UNSPECIFIED
780.2 SYNCOPE AND COLLAPSE
785.1 PALPITATIONS
E942.0* CARDIAC RHYTHM REGULATORS CAUSING ADVERSE EFFECTS IN THERAPEUTIC USE
E942.1* CARDIOTONIC GLYCOSIDES AND DRUGS OF SIMILAR ACTION CAUSING ADVERSE EFFECTS IN THERAPEUTIC USE
V45.00* UNSPECIFIED CARDIAC DEVICE IN SITU
V45.01* CARDIAC PACEMAKER IN SITU
V45.02* AUTOMATIC IMPLANTABLE CARDIAC DEFIBRILLATOR IN SITU
V45.09* OTHER SPECIFIED CARDIAC DEVICE IN SITU
V67.51 FOLLOW-UP EXAMINATION FOLLOWING COMPLETED TREATMENT WITH HIGH-RISK MEDICATION NOT ELSEWHERE CLASSIFIED
* According to the ICD-9-CM book, diagnosis codes E942.0, E942.1, V45.00, V45.01, V45.02 and V45.09 are secondary diagnosis codes and should not be billed as the primary diagnosis.
Documentation Requirements
• Medical record documentation maintained by the ordering/referring physician must clearly indicate the medical necessity of holter monitor studies covered by the Medicare program.
o Also, the results of holter studies covered by the Medicare program must be included in the patient's medical record.
• If the provider of holter studies is other than the ordering/referring physician, the provider of the service must maintain hard copy documentation of test results and interpretation along with copies of the ordering/referring physician's order for the study.
o When ordering holter studies from an independent physiological lab or other provider, the ordering/referring physician must state the reason for the holter study in his order for the test.
Utilization Guidelines
• It is expected that these services would be performed as indicated by current medical literature and/or standards of practice.
• When services are performed in excess of established parameters, they may be subject to review for medical necessity.
Treatment Logic
• Electrocardiographic monitoring can be performed on ambulatory patients over a set period of time (usually twenty four hours).
• The monitoring device (holter monitor) allows the patient to resume their normal lifestyle and activities while recording episodes of arrhythmia.
• This gives the physician documented episodes of arrhythmias or absence of arrhythmias to correlate with the patient's symptoms.
Sources of Information and Basis for Decision
Abbott, A. (2005). Diagnostic Approach to Palpitations. American Family Physician 71(4).
Arend, W., Armitage, J., Drazen, J., Eds, et al (2004). Goldman: Cecil Textbook of Medicine, 22nd ed. W.B. Saunders Company.
Sivaskumaran, S., Krahn, A., et al (2003). A prospective randomized comparison of loop recorders versus Holter monitors in patients with syncope or presyncope. American Journal of Medicine 115 (1).
Zipes, D., Libby, P., et al (2005). Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. Elsevier.
10/08/2012
The official local coverage determination (LCD) is the version on the Medicare coverage database at www.cms.gov/medicare-coverage-database/.
AMA CPT / ADA CDT Copyright Statement
CPT codes, descriptions and other data only are copyright 2011 American Medical Association (or such other date of publication of CPT). All Rights Reserved. Applicable FARS/DFARS Clauses Apply. Current Dental Terminology, (CDT) (including procedure codes, nomenclature, descriptors and other data contained therein) is copyright by the American Dental Association. © 2002, 2004 American Dental Association. All rights reserved. Applicable FARS/DFARS apply.
Local Coverage Determination (LCD) External Electrocardiographic Recording (L29162)